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Background: Experimental tissue fusion benefits from the selective heating of superparamag-
netic iron oxide nanoparticles (SPIONs) under high frequency irradiation. However, the meta-
bolic pathways of SPIONs for tissue fusion remain unknown. Hence, the goal of this in vivo study 
was to analyze the distribution of SPIONs in different organs by means of magnetic resonance 
imaging (MRI) and histological analysis after a SPION-containing patch implantation.
Methods: SPION-containing patches were implanted in rats. Three animal groups were   studied 
histologically over six months. Degradation assessment of the SPION-albumin patch was per-
formed in vivo using MRI for iron content localization and biodistribution.
Results: No SPION degradation or accumulation into the reticuloendothelial system was 
detected by MRI, MRI relaxometry, or histology, outside the area of the implantation patch. 
Concentrations from 0.01 µg/mL to 25 µg/mL were found to be hyperintense in T1-like   gradient 
echo sequences. The best differentiation of concentrations was found in T2 relaxometry, 
susceptibility-sensitive gradient echo sequences, and in high repetition time T2 images. 
  Qualitative and semiquantitative visualization of small concentrations and accumulation of 
SPIONs by MRI are feasible. In histological liver samples, Kupffer cells were significantly 
correlated with postimplantation time, but no differences were observed between sham-treated 
and induction/no induction groups. Transmission electron microscopy showed local uptake of 
SPIONs in macrophages and cells of the reticuloendothelial system. Apoptosis staining using 
caspase showed no increased toxicity compared with sham-treated tissue. Implanted SPION 
patches were relatively inert with slow, progressive local degradation over the six-month period. 
No distant structural alterations in the studied tissue could be observed.
Conclusion: Systemic bioavailability may play a role in specific SPION implant toxicity and 
therefore the local degradation process is a further aspect to be assessed in future studies.
Keywords: superparamagnetic iron oxide nanoparticles, metabolism, distribution
Introduction
Applications of superparamagnetic iron oxide nanoparticles (SPIONs) in medical 
diagnosis and therapy are based on two major advantages of iron oxides, ie, their 
low toxicity to human beings and their strong interaction with high frequency elec-
tromagnetic fields.1 Therefore, SPIONs have gained wide clinical acceptance in 
diagnostic radiology practice because they cause inhomogeneous susceptibility in 
magnetic resonance imaging (MRI) and change the relaxometry curves. However, 
their therapeutic applications in drug delivery, cell labeling, and tissue engineering 
are still under investigation.2 In addition, SPIONs can be used in minimally invasive 
sutureless surgery or hyperthermia, eg, in glioma therapy.3,4 In contrast with   commonly International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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used laser soldering techniques, electromagnetic tissue 
  soldering has the advantages of being free of practically any 
energy attenuation, while deposing energy and passing the 
tissue. Although SPION electromagnetic tissue soldering is 
possible, the metabolism and long-term effects on tissue of 
extracellularly deposited SPIONs is not yet tested. In con-
trast, the biodistribution of SPIONs used as an intravenous 
contrast agent for MRI is widely studied.2,5 Tissue distribu-
tion is mainly influenced by particle size, whereby larger 
SPIONs (over 50 nm in diameter) tend to rely on passive 
targeting, such as uptake by the reticuloendothelial system, 
and the smaller SPIONs (under 50 nm) benefit from slower 
opsonization and clearance from the reticuloendothelial 
system.6 In addition to particle size, the rate of hepatic clear-
ance of SPIONs depends on the coating material used on the 
iron oxide particles.7 Biodistribution, pharmacokinetics, and 
possible toxicity depend on properties such as particle size, 
surface morphology, and surface charge.8 In general, smaller 
particles circulate for longer than larger particles, and can be 
gradually taken up by the reticuloendothelial system in lymph 
tissue and bone marrow.8–13 Larger particles over 50 nm 
are generally taken up quickly by the reticuloendothelial 
system in Kupffer cells of the liver, and have limited uptake 
in lymph and bone tissues.6 The coating material rather than 
the mean hydrated size of the iron oxide particle contributes 
significantly to the rate of iron oxide particle clearance and 
degradation in sinusoidal Kupffer liver cells, especially 
for particles smaller than 40 nm in diameter.7 Overall, iron 
oxide particles with coating materials which limit or hinder 
water access to the core exhibit significantly longer degra-
dation rates, as reflected by the increased half-life of these 
particles in the liver.7 No toxic effects have been reported 
for these hydrated SPION contrast agents. In addition to size 
and surface coating, the surface charge of SPIONs plays a 
critical role in their half-life in blood. Positively charged 
particles tend to adhere nonspecifically to cells.14 Strong 
negative charges on the surface are also detrimental in that 
they result in increased liver uptake.7 In a recently published 
report, Hanini et al demonstrated that uncoated chemically 
engineered iron oxide nanoparticles can have harmful effects 
in the liver, kidney, and lungs when administered by a single 
intravenous injection.15
When using SPIONs for tissue soldering, their   specific size 
needs to be assessed for optimal heating   capability, because 
these SPIONs can be “tuned” with their   corresponding elec-
tromagnetic frequency, also referred to as Neél and Brownian 
relaxation.16 To generate a temperature of 80°C–100°C nec-
essary for strong and tight tissue fusion at a constant flux of 
40 mT for 60 seconds, the size of the SPIONs should be about 
15 nm.17 The uncoated SPIONs were mixed with albumin in 
a semidry formulation as used for tissue soldering. No toxic 
effect from albumin on local cellular levels after ingestion 
has been reported in fibroblasts.18
The objective of this study was to analyze specific SPIONs 
for use in tissue soldering and to find the possible pathways 
of the SPIONs in question from the site of implantation.3 
Therefore, SPIONs were tracked using a magnetic resonance 
tracking method as well as histological assessment of the 
organs involved in degradation and excretion.   Kuhlpeter et al 
reported recently that SPIONS can be detected, even in minute 
concentrations.19 We aimed to quantify these concentrations in 
an in vitro dilution series. The potential toxic effects elicited 
by iron oxide nanoparticles are addressed in the discussion.
Materials and methods
Local resorption of SPIONs after subcutaneous implantation 
of a SPION-albumin patch and the effect on remote organs 
were evaluated over a six-month period in vivo in three animal 
groups. SPION tracking was performed using MRI, histology, 
and transmission electron microscopy (TEM) to assess for the 
presence of SPIONs in selected organs. Prior to the in vivo 
experiments, a MRI tracking dilution series was performed 
in vitro to assess the limit of detection.
MrI investigations
All imaging was performed in a 3.0 Tesla scanner (Trio TIM, 
Siemens, Erlangen, Germany) with a 12-channel head coil. 
While T2* relaxometry is known to show better contrast 
compared with T2 relaxometry, the T2* relaxometry is more 
sensitive to cell-bound SPIONs than to free SPIONs.19 T2 
relaxometry was preferred for semiquantitative measurements 
of both intracellular and extracellular SPION concentrations 
in tissue. Relaxometry was performed using a multicontrast 
spin echo sequence (repetition time 1500; echo time 12 msec 
to 96 msec in steps of 12 msec). The signal decay was calcu-
lated for each pixel assuming a monoexponential decay func-
tion S (TE, echo time) = A exp (-TE/-T2), where A = signal 
amplitude, which was normalized to 1 before application of 
a least square fit algorithm. The first value of each sequence 
measured at TE = 12 msec was omitted due to artifacts caused 
by the pulse sequence.20 Statistics were calculated using 
Excel® (Microsoft Corporation, Redmond, WA).
In vitro dilution series
Before in vivo assessment of iron by the MRI scanner, an in 
vitro dilution series of 0.01 µg/mL to 5 mg/mL was performed International Journal of Nanomedicine 2011:6
Table 1 histology and TeM results for all animals by treatment group at all study time points
Time Group A Group B Group C Total
With TEM Without TEM With TEM Without TEM With TEM Without TEM
1 day 1 – 1 – – 1 3
3 days – 1 – 1 – – 2
15 days – 1 – 1 – – 2
4 weeks 1 – 1 – – 1 3
3 months – 2 – 2 – 2 6
6 months 1 1 1 1 – 5 9
Total 3 5 3 5 0 9 25
Notes: histological analysis to measure iron concentrations in organs (liver, kidney, pancreas, brain) and local implantation area. MrI done in whole-body scan with regions 
of interest set at brain (nucleus caudatus), liver, and kidney. TeM was performed in groups A and B after day 1, week 4, and month 6. TeM analysis of the sham-operated 
group (group c) was not performed. 
Abbreviations: MrI, magnetic resonance imaging; TeM, transmission electron microscopy.
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to detect concentration-dependent susceptibility changes and 
to assess the lowest detectable level of SPION concentration. 
Different concentrations (0.01 µg/mL to 5 mg/mL) of 
uncoated Fe2O3 SPIONs (15 nm in diameter) were prepared 
in agarose and quantitatively analyzed in a 3 Tesla MRI (Trio 
TIM, Siemens) for signal alteration (T2 relaxometry using a 
multicontrast spin echo sequence and R2*.21) The region of 
interest for measurement in the sample tubes was set into the 
middle of the test tube to avoid partial volume effects.
In vivo experiments
SPION-albumin complex
A water-based suspension of Fe2O3 SPIONs with a particle 
diameter of 15 nm in combination with bovine serum albumin 
was used. The solder consisted therefore of 20% (w/w) bovine 
serum albumin (Cohn Factor V , Sigma Aldrich, Switzerland) 
dissolved in pure sterile water and mixed in a waterbath at 
37°C. The solder was then blended with the dissolved SPIONs 
(20% w/w), and dispersed in a Petri dish, and allowed to air-
dry in order to obtain an implantable solder patch. Patches of 
400 mm thickness were rolled and then cut using a predefined 
square cutter of 25 mm2. The weight of these patches was 
27.2 ± 0.3 mg, corresponding to 5.52 ± 0.07 mg of ferric oxide 
per patch. This resulted in a volume of 10 mm3 per patch and 
a Fe2O3 concentration of 552 mg/mL.
Animals
Twenty-five adult male Wistar rats weighing 300–360 g were 
included in the study. The experiments were performed with 
the approval of the Ethics Committee for Animal Experi-
ments at the Canton of Bern, Switzerland. The study design 
consisted of three groups, ie, group A, which had SPION-
albumin patch implantation followed by induction-based 
heating (n = 8), group B, which had SPION-albumin patch 
implantation without induction heating (n = 8), and group C, 
which was a sham control group (n = 9), the latter being 
included to distinguish iron degradation from postoperative 
hematoma and MRI artifacts. After anesthesia, the animal’s 
skull was shaved, a transverse incision of approximately 1 cm 
was made in the nuchal midline, and a small 1 cm pouch 
was prepared. In groups A and B, the implant was placed 
subcutaneously inside this small pouch. The incision was 
then closed using 4–0 Vicryl sutures (Ethicon, Johnson and 
Johnson, Schaffhausen, Switzerland) and disinfected. The 
animals were then returned to the animal facility, and their 
behavior and food intake were observed postoperatively.
MRI tracking was conducted for six months at several 
time points, ie, days 1, 3, and 15, week 4, and months 3 and 6. 
The regions of interest in the different measurement sites 
(liver, kidney, nucleus caudatus) were fixed in an image 
where anatomical structure was best delineated, then copied 
into the same position at other echo times in order to achieve 
identical voxels for measurement.
Induction heating
The animals in Group A were subjected to induction heating 
of the SPION-albumin patch after implantation as previ-
ously reported.22 Briefly, a high frequency generator (Power 
  Controller 32/1800, Ceia, Arezzo, Italy) was used, operating 
at a constant frequency of 1.8 mHz and a constant flux of 
40 mT. The coil was placed on the skin, 1–2 mm from the 
implant. The implant was induced for 60 seconds until a 
temperature of 80°C was reached.22–24
histological and ultrastructural analysis
Following MRI assessment, all animals were sacrificed and 
histologically analyzed (Table 1). The main area for histologi-
cal analysis was the local SPION-albumin patch implant area 
and SPION metabolism and distribution in organs, such as 
liver, pancreas, kidney, brain, and spleen. Immediately after International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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removal from the cadavers, tissue samples were fixed overnight 
in a 5% buffered aqueous solution of formaldehyde (Pharmacy 
Inselspital, Bern, Switzerland), and routinely processed in 
paraffin. Consecutive serial sections of 3 µm thickness were 
alternately stained with hematoxylin and eosin and Prussian 
Blue. All sections were examined under light microscopy in a 
diagnostic surgical pathology setting. Hematoxylin and eosin 
and Prussian Blue staining was performed at all time points.
To detect apoptotic cells we performed immunohis-
tochemical analyses for caspase-3 at three days and six 
months. For this purpose, two different primary antibodies 
and consequently two different staining protocols were used 
as follows. In the first protocol, sections were deparaffinized 
and then blocked by 0.1% Triton X-100 in phosphate-buffered 
saline plus 10% normal goat serum for 60 minutes, washed, 
and incubated overnight with the primary antibody (affin-
ity purified polyclonal rabbit antiactive caspase-3 antibody, 
1:1000, Promega, Madison, WI) with 0.1% Triton X-100 in 
phosphate-buffered saline plus 2.5% horse serum at 4°C. 
Bound antibodies were visualized using the Vectastain method 
(Vector Laboratories) in combination with a metal-enhanced 
3,3′-diaminobenzidine substrate kit as previously described.26 
In the second protocol, after deparaffinization, the sections 
were incubated in primary antibodies (monoclonal rabbit 
anticleaved caspase-3 antibody, 1:100, Cell Signaling Tech-
nology, Beverly, MA) in phosphate-buffered saline containing 
5% normal goat serum and 0.5% casein for 60 minutes.25 
Sections were then treated as described above, dehydrated 
in alcohol, cleared in xylene, and mounted in Eukitt. Stain-
ing control adjacent sections were incubated in the absence 
of primary antibodies. In addition, cultured striatal cells 
exposed to 3-nitropropionic acid served as positive controls 
for caspase-3 staining.27 TEM was performed on specimens of 
the SPION-albumin patch implant area and the liver after day 
1, week 4, and month 6 (groups A and B). No samples were 
analyzed in the sham-operated animals (group C).
Results
MrI in vitro dilution series
Susceptibility changes were demonstrated in all probes 
examined. Concentrations from 0.05 µg/mL to 25 µg/mL 
were found to be hyperintense in T1-like gradient echo 
sequences and increasingly hypointense in concentrations up 
to 5 mg/mL. The best differentiation of concentrations was 
found in T2 relaxometry values, susceptibility sensitive gradient 
echo sequences, and in high repetition time T2 images, in 
accordance with a method previously published by Kuhlpeter 
et al.19 In tissue-like environments, the detection limit was 
established for SPIONs by using T2 relaxometry effective 
down to 2.5 µg/mL.
Animal outcomes
All animals (n = 25) showed normal food intake and growth 
during the study period. All animals survived surgery, and the 
following MRI studies and observation period (Table 1).
MrI in vivo
MRI showed signal alterations in the implantation area through-
out the observation period (day 1, day 3, day 15, week 4, and 
months 3 and 6). Imaging and analysis of the regions of interest 
in the corresponding organs (liver, kidney, nucleus caudatus) 
gave no indication of altered T2 decay times due to diffuse 
and detectable concentrations of SPIONs. Figure 1 shows the 
primary regions of interest analyzed in each animal. The relax-
ation curves for the kidney, liver, and nucleus caudatus showed 
normal decay, with no divergent values due to iron accumula-
tion. Figure 2 shows the half-life periods for the treated animals 
compared with mean values for the control group.
Histological findings
None of the organs studied (brain, liver, spleen) showed 
either direct evidence of excessive iron accumulation or tissue 
alterations suggestive of iron overload. Liver changes in the 
form of increased numbers of Kupffer cells were found, but 
were identical in SPION-treated and sham-operated animals. 
This was most likely due to the trauma of surgery (Figure 3). 
At the implant site itself, the inflammatory exudate tended to 
be more granulocyte-rich in the absence of   electromagnetic 
heating, whereas mononuclear cells (lymphocytes and 
macrophages) were predominant near the heat pretreated 
Figure  1 Three  full-body  magnetic  resonance  scans  in  a  rat.  After  choosing  a 
suitable slice position for each rat, standardized regions of interest are placed in 
homogenous parts of (A) kidney, (B) liver, and (C) nucleus caudatus (marked with 
arrows) to measure and compare T2 relaxation times.International Journal of Nanomedicine 2011:6
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Figure 2 comparison of the half-life values in milliseconds of the decay curves in all 
tested (A) livers, (B) kidneys, and (C) nucleus caudatus of animals with implanted 
patches. For better visualization, the mean values for the sham-operated group is 
marked as a bar. The values show no systematic variation, regardless of whether a 
sham-operated, induction, or no induction group. Variation of values in the kidney 
is probably a normal phenomenon caused by nonhomogeneous regions of interest 
regarding the constantly changing water content. The same amplitude of variation 
can be found in the sham group.
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(soldered) implants. In the late phases of the observation 
period, the implant site tended to be largely organized by 
fibrous remodeling with no significant foreign body reac-
tion. The SPION-albumin complex was slowly reabsorbed 
over the observation period (Figures 4 and 5). Both active 
caspase-3 and cleaved caspase-3 apoptosis staining at day 3 
and month 6 occasionally showed some positive cells in the 
liver and local implant site, but no difference was observed 
between sham and treated animals (Figures 3 and 4).
Ultrastructural findings
TEM revealed that parts of the SPION-derived iron granules 
were engulfed by macrophages at the implantation site. 
No toxic effects caused by the SPIONs were demonstrated 
(Figure 6). In the liver, the selective storage of iron within 
the cytoplasm of Kupffer cells was assessed as normal physi-
ological activity (Figure 7).
Discussion
SPIONs in general may have different size and conforma-
tion status such as is seen in contrast agents, in contrast with 
hyperthermia and soldering situations. In this study, the 
SPIONs used for heating were prepared as single particles in 
an aqueous solution together with albumin. The histological 
and TEM images obtained from the subcutaneously 
implanted SPION-albumin complexes showed rather compact 
aggregates. The edges of the implant were exposed to slow 
degradation (Figure 5). TEM images showed intracellular 
aggregates of SPIONs, meaning that the distribution of 
the SPIONs did not follow the same clearance stages as 
described for SPIONs used as contrast agents. Intravascularly 
injected SPIONs were mainly found in the reticuloendothelial 
system of the liver. Furthermore, using MRI tracking, we 
were not able to detect any SPIONs or R2 changes in any 
of the observed organs, down to a concentration lower than 
2.5 µg/mL. Histological assessment, as well as TEM sections 
of the liver, was in accordance with these MRI findings, and 
showed no SPION-induced effect in comparison with the 
control group.
The amount of iron released by the SPION-albumin 
patch, in respect to systemic resorption, is so low that from 
this standpoint no toxic effects are expected. Adult humans 
ingest about 12–18 mg of dietary iron per day, and the 
mucosa alone absorbs about 1–2 mg per day.28 The maximum 
dose of iron released by the SPION-albumin patch using the 
amount of iron per patch (5.52 mg) corresponds to about 
double the daily dietary ingestion by a human adult. In a 
rat, this corresponds to about 36 times the dietary intake 
of iron per day (roughly 150 µg Fe).29 However, this is a 
single implant absorbed slowly over a period of more than 
six months. The implant is still present although dimin-
ished to about half of its initial configuration after more 
than 180 days. This would correspond to about an average 
of 15 µg Fe per day. As reported, histological and TEM 
analysis showed no toxic effect during the six-month study 
period. However, there was a small increase in Kupffer cells 
in the liver to be addressed, which corresponds to normal 
development over time, given that it was also observed 
in the sham-operated group and has been described in the 
literature in aging rats.30International Journal of Nanomedicine 2011:6
Figure 3 conventional light microscopic histology of representative rat liver tissue removed (A) three days and (B) six months after implantation of superparamagnetic iron 
oxide nanoparticles. (C) Liver tissue of a sham-treated animal after six months. All visual fields include a central vein. Neither iron storage in hepatocytes nor fibrosis is seen. 
Arrows in (B) and (C) point to minute iron deposits in a Kupffer cell flanking a sinusoid. This chance finding is due to age-related increase of Kupffer cells and is therefore 
less likely to be encountered in young animals. (A) Iron granules are readily distinguished from lipofuscin pigment using Prussian Blue staining (inset in C). Slides not labeled 
otherwise represent hematoxylin and eosin staining; original magnification 200×. representative section of rat liver using active caspase-3 antibody staining at three days (D) 
40× and cleaved caspase-3 antibody staining at six months (E) 40× demonstrated no apoptotic activity. Sham caspase is not shown because no difference was detected.
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In general, a foreign body giant cell formation from the 
fusion of macrophages has been observed as a result of the 
response induced by biomaterials and other foreign bodies, 
and we also found this in our study.31 The size and surface 
characteristics of these giant cells elicit a prolonged series 
of reactions, a process known as the foreign body response.31 
Although inflammation and macrophage activation resolve in 
the later stages of wound healing to promote tissue remodel-
ing, the foreign body response is characterized by persistence 
of inflammatory cells, particularly macrophages, at the site 
of implantation. On the implant surface, macrophages fuse 
into multinucleated giant cells. In comparison with single 
macrophages, giant cells are capable of delivering a more 
effective and concentrated assault on the implant, degrading 
material and even causing failure of implanted devices. The 
presence of giant cells was also observed in the implants 
used in our study, with a progressive degradation of the 
SPION implant over the six-month observation period, 
further undermining the low toxicity and iron systemic iron 
load over time.
Results differing from ours were recently published by 
Hanini et al, who demonstrated a toxic effect in the liver, 
kidney, and lungs after intravenous injection of 0.8 mg of 
iron oxide nanoparticles.15 In our study, we did not observe 
toxic effects because our SPIONs-containing implants did 
not induce structural changes in the liver and kidney, and 
also did not increase apoptosis as compared with controls. 
One possible explanation for this discrepancy in outcome 
may be the way in which the nanoparticles were released 
into the system. Slow degradation of the implant with the 
described foreign body response may be responsible for the 
slow systemic availability. A detailed quantification of this 
process up until complete resorption of the implant needs to 
be performed to elucidate this question fully.International Journal of Nanomedicine 2011:6
Figure 4 Histological findings of the superparamagnetic iron oxide nanoparticle-
albumin  complex  three  days  after  implantation  and  heat  treatment  in  an 
electromagnetic  field  for  60  seconds.  (A)  Scanning  magnification  shows  implant 
smoothly accommodated along the cleavage plane of subcutaneous fascia and axial 
musculature with no significant space-occupying effect. (B) Detailed view of implant/
tissue interface indicates this to consist of a narrow rim of fibrinoid exudate (arrows) 
surrounded by granulation tissue. Prussian Blue staining; original magnification (A) 
15× and B 100×. In (C), active caspase-3 antibody staining shows no apoptotic activity 
around the implant (40×). Sham not shown because no difference was detected.
AB
1.00 µm 10.00 µm
Figure 6 Ultrastructural aspect of implant/tissue interaction as seen on transmission 
electron  microscopy.  (A)  Detailed  view  of  early  phase  of  implant  degradation 
showing ongoing engulfment of the superparamagnetic iron oxide nanoparticles-
albumin complex by activated monocytes. heterogeneous electron density of implant 
material is seen, with electron-lucent zones corresponding to coagulated albumin (*) 
whereas dense granules represent iron nanoparticles (). (B) Organizing phase of 
implant scavenging is characterized by phagocytic cells replete with electron-dense 
iron particles. Note intercellular deposition of connective tissue fibers (arrows). 
Original magnification is indicated by scale bars.
Figure  7  Ultrastructural  aspect  of  liver  from  an  implant-bearing  animal  in  the 
late  phase  of  observation  period.  *Transected  biliary  canalicule  flanked  by  two 
hepatocytes, the cell borders of which (arrows) are not readily identified due to poor 
specimen preservation. regular aspect of mitochondria is a good indicator of lack 
of metabolic stress, as frequently seen in storage disorders. Original magnification 
is indicated by scale bar.
Figure  5  histological  aspect  of  superparamagnetic  iron  oxide  nanoparticle-
albumin complex in situ six months after implantation and heating procedure. (A) 
At scanning magnification of Prussian Blue-stained section, centrifugal fading rather 
than sharp circumscription of implant contours is seen (especially as opposed to 
Figure 7A). (B) and (C) represent consecutive section planes of boxed area in (A) 
to indicate gradual dissolution of implant iron content by macrophages. In parallel, 
there is fibroblastic ingrowth. Note absence of significant foreign body reaction. 
(A) and (C) Prussian Blue staining, (B) hematoxylin and eosin staining; original 
magnifications (A) 15× and (B) and (C) 200× .
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Our findings support the further development of SPIONs 
designed for inducing hyperthermia or tissue soldering in vivo 
and local application, first by the lack of R2 signal changes 
globally and in specific organs, excluding any SPIONs and 
iron accumulation. Secondly, light microscopic and TEM 
histology and apoptosis staining of the excretion-related 
organs were unaffected by the SPIONs. Systemic availabil-
ity and specific SPION application may be important in the 
development of a possible toxic effect, as suggested by the 
discordant findings of Hanini et al and the outcome seen in the 
present study. Hence, prior to clinical application in a clini-
cal setting, decomposition of the complete SPION implant International Journal of Nanomedicine
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should be assessed in detail at the site of implantation over a 
considerable period of time.
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